A rapid pyrosequencing assay for the molecular detection of influenza viruses with reduced baloxavir susceptibility due to PA/I38X amino acid substitutions-Reference-Cited by-同舟云学术

A rapid pyrosequencing assay for the molecular detection of influenza viruses with reduced baloxavir susceptibility due to PA/I38X amino acid substitutions

Published:2020-02-11 Issue:4 Volume:14 Page:460-464
ISSN:1750-2640
Container-title:Influenza and Other Respiratory Viruses
language:en
Short-container-title:Influenza Other Respi Viruses

Author:

Koszalka Paulina¹²^ORCID,Farrukee Rubaiyea¹³,Mifsud Edin¹³,Vijaykrishna Dhanasekaran¹²,Hurt Aeron C.¹³^ORCID

Affiliation:

1. WHO Collaborating Centre for Reference and Research on Influenza VIDRL Peter Doherty Institute for Infection and Immunity Melbourne VIC Australia

2. Department of Microbiology Biomedicine Discovery Institute Monash University Melbourne VIC Australia

3. Department of Microbiology and Immunology University of Melbourne Parkville VIC Australia

Funder

Department of Health and Ageing, Australian Government

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,Pulmonary and Respiratory Medicine,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/irv.12725

Reference15 articles.

1. Baloxavir: First Global Approval

2. Characterization of influenza virus variants induced by treatment with the endonuclease inhibitor baloxavir marboxil

3. Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents

4. Human-to-Human Transmission of Influenza A(H3N2) Virus with Reduced Susceptibility to Baloxavir, Japan, February 2019

5. Assessing baloxavir susceptibility of influenza viruses circulating in the United States during the 2016/17 and 2017/18 seasons

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Report on influenza viruses received and tested by the Melbourne WHO Collaborating Centre for Reference and Research on Influenza during 2022;Communicable Diseases Intelligence;2023-01-19

2. An optimized cell-based assay to assess influenza virus replication by measuring neuraminidase activity and its applications for virological surveillance;Antiviral Research;2022-12

3. Assessing the fitness of a dual-antiviral drug resistant human influenza virus in the ferret model;Communications Biology;2022-09-28

4. Generation and Characterization of Drug-Resistant Influenza B Viruses Selected In Vitro with Baloxavir Acid;Pathogens;2022-09-15

5. Effect of Baloxavir and Oseltamivir in Combination on Infection with Influenza Viruses with PA/I38T or PA/E23K Substitutions in the Ferret Model;mBio;2022-08-30